ACE2 and COVID-19: According to the theoretical basis and the enrichment results that tuftsin could target ACE2 and NRP1 in the COVID-19 pathway, the possible interactions of tuftsin with the two SARS-CoV-2 entry receptors were determined by molecular docking analyses.